去勢抵抗性前立腺がんの世界市場：治療タイプ別、薬剤クラス別、投与経路別、流通チャネル別、地域別

世界の去勢抵抗性前立腺がんの市場規模は、2025年には106億6,000万米ドルと推定され、2032年には192億6,000万米ドルに達すると予測され、2025年～2032年にCAGR8.8％で成長すると予測されます。

図.去勢抵抗性前立腺がん市場シェア（%）、2025年、地域別

世界の去勢抵抗性前立腺がん市場の成長は、世界の前立腺がんの有病率の上昇が牽引しています。前立腺がんは、男性の間でよく発生するがんの一つです。2020年の米国がん協会のデータによると、米国では約19万1,930件の前立腺がんの新規症例が報告されています。テストステロンレベルを下げたり、その作用を阻害する内科的または外科的治療にもかかわらず、がんが転移し、成長し始めると、去勢抵抗性前立腺がん（CRPC）と呼ばれます。現在利用可能なCRPCの治療法には、化学療法、免疫療法、放射線療法などがあります。しかし、抵抗性の開発は、この進行期の前立腺がんを効果的に管理する上で、依然として大きな課題です。新規の創薬ターゲットや治療アプローチに関する現在進行中の研究により、治療抵抗性を克服し、CRPCにおける患者の転帰を改善することができます。

市場力学：

世界の去勢抵抗性前立腺がん市場の成長は、前立腺がんに罹患しやすい高齢者人口の増加が牽引しています。UN World Population Prospects 2020のデータによると、65歳以上の人口は2020年の7億300万人から2050年には15億人になると予測されています。前立腺がんに対する認識と検診率の向上も、前立腺がんの早期発見に拍車をかけており、市場成長の原動力となっています。しかし、免疫療法や標的治療レジメンに関連する高額な治療費が市場成長の妨げとなる可能性があります。薬剤耐性を克服するための新たなメカニズムを開発するための継続的な研究は、市場関係者に有望な機会を提供する可能性があります。手頃な価格のバイオシミラーの開発により、治療費を削減することができます。

本調査の主な特徴

• 本レポートは、世界の去勢抵抗性前立腺がん市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模とCAGR%を提供しています。
• また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、財務実績、戦略などのパラメータに基づいて、世界の去勢抵抗性前立腺がん市場における主要企業プロファイルを掲載しています。
• このレポートからの洞察により、マーケティング担当者や企業の経営陣は、将来の製品発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことができます。
• 世界の去勢抵抗性前立腺がん市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者に対応しています。
• 利害関係者は、世界の去勢抵抗性前立腺がん市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• Coherent Opportunity Map（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 主な発展
• 規制シナリオ
• 買収と提携のシナリオ
• 資金調達と投資
• PEST分析
• ポーターの分析

第4章 世界の去勢抵抗性前立腺がん市場：COVID-19パンデミックの影響

• 全体的な影響
• 政府の取り組み
• COVID-19による市場への影響

第5章 去勢抵抗性前立腺がんの世界市場：治療タイプ別（2020年～2032年）

• ホルモン療法
• 免疫療法
• 化学療法
• 放射線治療

第6章 去勢抵抗性前立腺がんの世界市場：薬剤クラス別（2020年～2032年）

• 抗腫瘍薬
• 非ステロイド性抗アンドロゲン
• コルチコステロイド
• 微小管阻害剤
• その他

第7章 世界の去勢抵抗性前立腺がん市場：流通チャネル別（2020年～2032年）

• 院内薬局
• 小売薬局
• オンライン薬局

第8章 去勢抵抗性前立腺がんの世界市場：投与経路別（2020年～2032年）

• 経口
• 注射

第9章 世界の去勢抵抗性前立腺がん市場：地域別（2020年～2032年）

• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第10章 競合情勢

• 企業プロファイル
  • Trelleborg Sealing Solutions
  • Freudenberg Group
  • Parker Hannifin Corp
  • Saint-Gobain
  • Bal Seal Engineering, Inc.
  • Flexan
  • Marco Rubber &Plastics
  • Morgan Polymer Seals
  • Minnesota Rubber and Plastics
  • Precision Associates, Inc.
  • IDEX Health &Science LLC
  • Apple Rubber Products
  • Technetics Group
  • Sterne SAS
  • ResMed
  • West Pharmaceutical Services, Inc.

第11章 アナリストの推奨事項

• 運命の輪
• アナリストの見解
• Coherent Opportunity Map（COM）

第12章 参考文献と調査手法

• 参考文献
• 調査手法

Global Castrate Resistant Prostate Cancer Market is estimated to be valued at USD 10.66 Bn in 2025 and is expected to reach USD 19.26 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032.

Figure. Castrate Resistant Prostate Cancer Market Share (%), By Region 2025

Global castrate resistant prostate cancer market growth is driven by rising prevalence of prostate cancer worldwide. Prostate cancer is one of the commonly occurring cancers among men. According to the data from American Cancer Society in 2020, around 191,930 new cases of prostate cancer were reported in the U.S. Once the cancer has metastasized and started growing despite medical or surgical therapy to reduce testosterone levels or block its action, it is termed as castrate resistant prostate cancer (CRPC). Currently available treatment options for CRPC include chemotherapy, immunotherapy, radiation therapy, and others. However, development of resistance remains a major challenge in effectively managing this advanced stage of prostate cancer. Ongoing research for novel drug targets and therapeutic approaches can overcome treatment resistance and improve patient outcomes in CRPC.

Market Dynamics:

Global castrate resistant prostate cancer market growth is driven by rising geriatric population susceptible to developing prostate cancer. According to the data from UN World Population Prospects 2020, the number of people aged 65 years or above is projected to grow from 703 million in 2020 to 1.5 billion in 2050 globally. Increasing awareness and screening rates have also augmented the early detection of prostate cancer, thus, driving the market growth. However, high treatment costs associated with immunotherapy and targeted therapy regimens can hamper the market growth. Ongoing research to develop novel mechanisms for overcoming drug resistance can offer promising opportunities for market players. Development of affordable biosimilars can reduce treatment costs.

Key Features of the Study:

• This report provides in-depth analysis of the global castrate resistant prostate cancer market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global castrate resistant prostate cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Johnson & Johnson, Astellas Pharma, Sanofi, Dendreon, Bayer, and others
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global castrate resistant prostate cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global castrate resistant prostate cancer market

Detailed Segmentation-

• By Therapy Type
  • Hormonal Therapy
  • Immunotherapy
  • Chemotherapy
  • Radiotherapy
• By Drug Class
  • Antineoplastic
  • Non-steroidal Antiandrogen
  • Corticosteroids
  • Microtubule Inhibitor
  • Others
• By Route of Administration
  • Oral
  • Injectable
• By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• By Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • Trelleborg Sealing Solutions
  • Freudenberg Group
  • Parker Hannifin Corp
  • Saint-Gobain
  • Bal Seal Engineering, Inc.
  • Flexan
  • Marco Rubber & Plastics
  • Morgan Polymer Seals
  • Minnesota Rubber and Plastics
  • Precision Associates, Inc.
  • IDEX Health & Science LLC
  • Apple Rubber Products
  • Technetics Group
  • Sterne S.A.S.
  • ResMed
  • West Pharmaceutical Services, Inc.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Therapy Type
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Route of Administration
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Acquisitions and Partnerships Scenario
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Castrate Resistant Prostate Cancer Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Castrate Resistant Prostate Cancer Market, By Therapy Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hormonal Therapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Chemotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Radiotherapy
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Castrate Resistant Prostate Cancer Market, By Drug Class, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Antineoplastic
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Non-steroidal Antiandrogen
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Corticosteroids
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microtubule Inhibitor
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Castrate Resistant Prostate Cancer Market, By Distribution Channel, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Castrate Resistant Prostate Cancer Market, By Route of Administration, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oral
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Injectable
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Castrate Resistant Prostate Cancer Market, By Region, 2020 - 2032, (USDBn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2021-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

10. Competitive Landscape

• Company Profiles
  • Trelleborg Sealing Solutions
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Freudenberg Group
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Parker Hannifin Corp
    • Company Highlights
    • Method Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Saint-Gobain
  • Bal Seal Engineering, Inc.
  • Flexan
  • Marco Rubber & Plastics
  • Morgan Polymer Seals
  • Minnesota Rubber and Plastics
  • Precision Associates, Inc.
  • IDEX Health & Science LLC
  • Apple Rubber Products
  • Technetics Group
  • Sterne S.A.S.
  • ResMed
  • West Pharmaceutical Services, Inc.

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About Us and Sales Contact